Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 2/2017

13.05.2017

Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

verfasst von: Patrice Hemon, Yves Renaudineau, Marjolaine Debant, Nelig Le Goux, Sreya Mukherjee, Wesley Brooks, Olivier Mignen

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Maintenance of self-tolerance of auto-reactive lymphocytes is a fundamental mechanism to prevent the onset of autoimmune diseases. Deciphering the mechanisms involved in the deregulations leading to tolerance disruption and autoimmunity is still a major area of interest to identify new therapeutic targets and options. Ca2+ signaling plays a major role in B cell normal development and is therefore finely tuned by B cell receptor (BCR)-dependent and independent pathways. Developmental changes in the characteristics of BCR-dependent Ca2+ signals as well as the modulation of basal intracellular concentration ([Ca2+]i) contribute strongly to self-tolerance maintaining mechanisms responsible for the physical or functional elimination of autoreactive B cells such as clonal deletion, receptor editing, and anergy. Implication of Ca2+ signals in B tolerance mechanisms mainly occurs through the specific activation of transcriptional programs depending on the amplitude, shape, and duration of Ca2+ signals. A large number of studies reported Ca2+ signaling defects in autoimmune pathology such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and primary Sjӧgren’s syndrome (pSS). However, the precise nature of the molecular events responsible for these deregulations is not fully understood. Moreover, the demonstration of a direct correlation between Ca2+ signaling defects and tolerance disruption is still lacking. The recent identification of proteins involved in B cell Ca2+ signals such as ORAI, stromal interaction molecule and transient receptor potential is opening new horizons for understanding Ca2+ signaling defects observed in autoimmune diseases and for proposing potentially new therapeutic solutions. This review aims to present an overview of the developmental evolution of BCR dependent Ca2+ signaling and to place this signaling pathway in the context of mechanisms involved in tolerance maintenance and breakdown.
Literatur
4.
Zurück zum Zitat Melamed D, Benschop RJ, Cambier JC, Nemazee D (1998) Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 92(2):173–182PubMedCrossRef Melamed D, Benschop RJ, Cambier JC, Nemazee D (1998) Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 92(2):173–182PubMedCrossRef
5.
Zurück zum Zitat Gay D, Saunders T, Camper S, Weigert M (2011) Receptor editing: an approach by autoreactive B cells to escape tolerance. The Journal of Experimental Medicine. 1993. 177: 999–1008. Journal of Immunology 186 (3):1303–1312 Gay D, Saunders T, Camper S, Weigert M (2011) Receptor editing: an approach by autoreactive B cells to escape tolerance. The Journal of Experimental Medicine. 1993. 177: 999–1008. Journal of Immunology 186 (3):1303–1312
6.
Zurück zum Zitat Gay D, Saunders T, Camper S, Weigert M (1993) Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 177(4):999–1008PubMedCrossRef Gay D, Saunders T, Camper S, Weigert M (1993) Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 177(4):999–1008PubMedCrossRef
12.
Zurück zum Zitat Debant M, Hemon P, Brigaudeau C, Renaudineau Y, Mignen O (2015) Calcium signaling and cell fate: how can Ca2+ signals contribute to wrong decisions for chronic lymphocytic leukemic B lymphocyte outcome? Int J Dev Biol 59(7–9):379–389. doi:10.1387/ijdb.150204om PubMedCrossRef Debant M, Hemon P, Brigaudeau C, Renaudineau Y, Mignen O (2015) Calcium signaling and cell fate: how can Ca2+ signals contribute to wrong decisions for chronic lymphocytic leukemic B lymphocyte outcome? Int J Dev Biol 59(7–9):379–389. doi:10.​1387/​ijdb.​150204om PubMedCrossRef
13.
Zurück zum Zitat Mori Y, Wakamori M, Miyakawa T, Hermosura M, Hara Y, Nishida M, Hirose K, Mizushima A, Kurosaki M, Mori E, Gotoh K, Okada T, Fleig A, Penner R, Iino M, Kurosaki T (2002) Transient receptor potential 1 regulates capacitative Ca(2+) entry and Ca(2+) release from endoplasmic reticulum in B lymphocytes. J Exp Med 195(6):673–681PubMedPubMedCentralCrossRef Mori Y, Wakamori M, Miyakawa T, Hermosura M, Hara Y, Nishida M, Hirose K, Mizushima A, Kurosaki M, Mori E, Gotoh K, Okada T, Fleig A, Penner R, Iino M, Kurosaki T (2002) Transient receptor potential 1 regulates capacitative Ca(2+) entry and Ca(2+) release from endoplasmic reticulum in B lymphocytes. J Exp Med 195(6):673–681PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Garaud S, Taher TE, Debant M, Burgos M, Melayah S, Berthou C, Parikh K, Pers JO, Luque-Paz D, Chiocchia G, Peppelenbosch M, Isenberg DA, Youinou P, Mignen O, Renaudineau Y, Mageed RA (2016) CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes. Cell Mol Immunol. doi:10.1038/cmi.2016.42 PubMed Garaud S, Taher TE, Debant M, Burgos M, Melayah S, Berthou C, Parikh K, Pers JO, Luque-Paz D, Chiocchia G, Peppelenbosch M, Isenberg DA, Youinou P, Mignen O, Renaudineau Y, Mageed RA (2016) CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes. Cell Mol Immunol. doi:10.​1038/​cmi.​2016.​42 PubMed
16.
Zurück zum Zitat Tedder TF, Haas KM, Poe JC (2002) CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses. Biochem Soc Trans 30(4):807–811. doi:10.1042/bst0300807 PubMedCrossRef Tedder TF, Haas KM, Poe JC (2002) CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses. Biochem Soc Trans 30(4):807–811. doi:10.​1042/​bst0300807 PubMedCrossRef
20.
Zurück zum Zitat Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC (1997) CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 7(2):133–143PubMedCrossRef Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC (1997) CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 7(2):133–143PubMedCrossRef
21.
Zurück zum Zitat Jang IK, Cronshaw DG, Xie LK, Fang G, Zhang J, Oh H, Fu YX, Gu H, Zou Y (2011) Growth-factor receptor-bound protein-2 (Grb2) signaling in B cells controls lymphoid follicle organization and germinal center reaction. Proceedings of the National Academy of Sciences of the United States of America 108 (19):7926–7931. doi:10.1073/pnas.1016451108 Jang IK, Cronshaw DG, Xie LK, Fang G, Zhang J, Oh H, Fu YX, Gu H, Zou Y (2011) Growth-factor receptor-bound protein-2 (Grb2) signaling in B cells controls lymphoid follicle organization and germinal center reaction. Proceedings of the National Academy of Sciences of the United States of America 108 (19):7926–7931. doi:10.​1073/​pnas.​1016451108
24.
Zurück zum Zitat Miller AT, Beisner DR, Liu D, Cooke MP (2009) Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance induction. J Immunol 182(8):4696–4704. doi:10.4049/jimmunol.0802850 PubMedCrossRef Miller AT, Beisner DR, Liu D, Cooke MP (2009) Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance induction. J Immunol 182(8):4696–4704. doi:10.​4049/​jimmunol.​0802850 PubMedCrossRef
25.
Zurück zum Zitat Miller AT, Dahlberg C, Sandberg ML, Wen BG, Beisner DR, Hoerter JA, Parker A, Schmedt C, Stinson M, Avis J, Cienfuegos C, McPate M, Tranter P, Gosling M, Groot-Kormelink PJ, Dawson J, Pan S, Tian SS, Seidel HM, Cooke MP (2015) Inhibition of the inositol kinase Itpkb augments calcium signaling in lymphocytes and reveals a novel strategy to treat autoimmune disease. PLoS One 10(6):e0131071. doi:10.1371/journal.pone.0131071 PubMedPubMedCentralCrossRef Miller AT, Dahlberg C, Sandberg ML, Wen BG, Beisner DR, Hoerter JA, Parker A, Schmedt C, Stinson M, Avis J, Cienfuegos C, McPate M, Tranter P, Gosling M, Groot-Kormelink PJ, Dawson J, Pan S, Tian SS, Seidel HM, Cooke MP (2015) Inhibition of the inositol kinase Itpkb augments calcium signaling in lymphocytes and reveals a novel strategy to treat autoimmune disease. PLoS One 10(6):e0131071. doi:10.​1371/​journal.​pone.​0131071 PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR (2001) Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 167(12):6834–6840PubMedCrossRef Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR (2001) Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 167(12):6834–6840PubMedCrossRef
31.
Zurück zum Zitat Gauld SB, Benschop RJ, Merrell KT, Cambier JC (2005) Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol 6(11):1160–1167. doi:10.1038/ni1256 PubMedCrossRef Gauld SB, Benschop RJ, Merrell KT, Cambier JC (2005) Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol 6(11):1160–1167. doi:10.​1038/​ni1256 PubMedCrossRef
32.
Zurück zum Zitat Benschop RJ, Aviszus K, Zhang X, Manser T, Cambier JC, Wysocki LJ (2001) Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity 14(1):33–43PubMedCrossRef Benschop RJ, Aviszus K, Zhang X, Manser T, Cambier JC, Wysocki LJ (2001) Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity 14(1):33–43PubMedCrossRef
34.
Zurück zum Zitat Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crabtree GR, Lewis RS, Goodnow CC (1997) Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6(4):419–428PubMedCrossRef Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crabtree GR, Lewis RS, Goodnow CC (1997) Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6(4):419–428PubMedCrossRef
35.
Zurück zum Zitat Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K et al (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334(6184):676–682. doi:10.1038/334676a0 PubMedCrossRef Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K et al (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334(6184):676–682. doi:10.​1038/​334676a0 PubMedCrossRef
36.
Zurück zum Zitat Cooke MP, Heath AW, Shokat KM, Zeng Y, Finkelman FD, Linsley PS, Howard M, Goodnow CC (1994) Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 179(2):425–438PubMedCrossRef Cooke MP, Heath AW, Shokat KM, Zeng Y, Finkelman FD, Linsley PS, Howard M, Goodnow CC (1994) Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 179(2):425–438PubMedCrossRef
39.
Zurück zum Zitat Teague BN, Pan Y, Mudd PA, Nakken B, Zhang Q, Szodoray P, Kim-Howard X, Wilson PC, Farris AD (2007) Cutting edge: transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus. J Immunol 178(12):7511–7515PubMedCrossRef Teague BN, Pan Y, Mudd PA, Nakken B, Zhang Q, Szodoray P, Kim-Howard X, Wilson PC, Farris AD (2007) Cutting edge: transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus. J Immunol 178(12):7511–7515PubMedCrossRef
40.
Zurück zum Zitat Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, Lee EH, Milner EC, Sanz I (2007) A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 178(10):6624–6633PubMedCrossRef Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, Lee EH, Milner EC, Sanz I (2007) A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 178(10):6624–6633PubMedCrossRef
41.
42.
Zurück zum Zitat Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, Mathias M, Garman L, Helms C, Nakken B, Smith K, Farris AD, Wilson PC (2009) Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med 206(1):139–151. doi:10.1084/jem.20080611 PubMedPubMedCentralCrossRef Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, Mathias M, Garman L, Helms C, Nakken B, Smith K, Farris AD, Wilson PC (2009) Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med 206(1):139–151. doi:10.​1084/​jem.​20080611 PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Cappione A 3rd, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, Sanz I (2005) Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 115(11):3205–3216. doi:10.1172/JCI24179 PubMedPubMedCentralCrossRef Cappione A 3rd, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, Sanz I (2005) Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 115(11):3205–3216. doi:10.​1172/​JCI24179 PubMedPubMedCentralCrossRef
44.
45.
Zurück zum Zitat Reichlin A, Hu Y, Meffre E, Nagaoka H, Gong S, Kraus M, Rajewsky K, Nussenzweig MC (2001) B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta. J Exp Med 193(1):13–23PubMedPubMedCentralCrossRef Reichlin A, Hu Y, Meffre E, Nagaoka H, Gong S, Kraus M, Rajewsky K, Nussenzweig MC (2001) B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta. J Exp Med 193(1):13–23PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Benschop RJ, Cambier JC (1999) B cell development: signal transduction by antigen receptors and their surrogates. Curr Opin Immunol 11(2):143–151PubMedCrossRef Benschop RJ, Cambier JC (1999) B cell development: signal transduction by antigen receptors and their surrogates. Curr Opin Immunol 11(2):143–151PubMedCrossRef
47.
Zurück zum Zitat Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8(4):497–508PubMedCrossRef Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8(4):497–508PubMedCrossRef
50.
Zurück zum Zitat Hoek KL, Antony P, Lowe J, Shinners N, Sarmah B, Wente SR, Wang D, Gerstein RM, Khan WN (2006) Transitional B cell fate is associated with developmental stage-specific regulation of diacylglycerol and calcium signaling upon B cell receptor engagement. J Immunol 177(8):5405–5413PubMedCrossRef Hoek KL, Antony P, Lowe J, Shinners N, Sarmah B, Wente SR, Wang D, Gerstein RM, Khan WN (2006) Transitional B cell fate is associated with developmental stage-specific regulation of diacylglycerol and calcium signaling upon B cell receptor engagement. J Immunol 177(8):5405–5413PubMedCrossRef
52.
Zurück zum Zitat Miller AT, Sandberg M, Huang YH, Young M, Sutton S, Sauer K, Cooke MP (2007) Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation. Nat Immunol 8(5):514–521. doi:10.1038/ni1458 PubMedCrossRef Miller AT, Sandberg M, Huang YH, Young M, Sutton S, Sauer K, Cooke MP (2007) Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation. Nat Immunol 8(5):514–521. doi:10.​1038/​ni1458 PubMedCrossRef
54.
Zurück zum Zitat Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI, Akkaraju S, Rathmell JC, Pogue SL, Shokat KP (1995) Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 59:279–368PubMedCrossRef Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI, Akkaraju S, Rathmell JC, Pogue SL, Shokat KP (1995) Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 59:279–368PubMedCrossRef
55.
Zurück zum Zitat Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI (1997) Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386(6627):855–858. doi:10.1038/386855a0 PubMedCrossRef Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI (1997) Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386(6627):855–858. doi:10.​1038/​386855a0 PubMedCrossRef
57.
Zurück zum Zitat Benschop RJ, Melamed D, Nemazee D, Cambier JC (1999) Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells. J Exp Med 190(6):749–756PubMedPubMedCentralCrossRef Benschop RJ, Melamed D, Nemazee D, Cambier JC (1999) Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells. J Exp Med 190(6):749–756PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Hayashi K, Nojima T, Goitsuka R, Kitamura D (2004) Impaired receptor editing in the primary B cell repertoire of BASH-deficient mice. J Immunol 173(10):5980–5988PubMedCrossRef Hayashi K, Nojima T, Goitsuka R, Kitamura D (2004) Impaired receptor editing in the primary B cell repertoire of BASH-deficient mice. J Immunol 173(10):5980–5988PubMedCrossRef
61.
Zurück zum Zitat Tze LE, Schram BR, Lam KP, Hogquist KA, Hippen KL, Liu J, Shinton SA, Otipoby KL, Rodine PR, Vegoe AL, Kraus M, Hardy RR, Schlissel MS, Rajewsky K, Behrens TW (2005) Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol 3(3):e82. doi:10.1371/journal.pbio.0030082 PubMedPubMedCentralCrossRef Tze LE, Schram BR, Lam KP, Hogquist KA, Hippen KL, Liu J, Shinton SA, Otipoby KL, Rodine PR, Vegoe AL, Kraus M, Hardy RR, Schlissel MS, Rajewsky K, Behrens TW (2005) Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol 3(3):e82. doi:10.​1371/​journal.​pbio.​0030082 PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Schram BR, Tze LE, Ramsey LB, Liu J, Najera L, Vegoe AL, Hardy RR, Hippen KL, Farrar MA, Behrens TW (2008) B cell receptor basal signaling regulates antigen-induced Ig light chain rearrangements. J Immunol 180(7):4728–4741PubMedCrossRef Schram BR, Tze LE, Ramsey LB, Liu J, Najera L, Vegoe AL, Hardy RR, Hippen KL, Farrar MA, Behrens TW (2008) B cell receptor basal signaling regulates antigen-induced Ig light chain rearrangements. J Immunol 180(7):4728–4741PubMedCrossRef
64.
Zurück zum Zitat Verkoczy L, Duong B, Skog P, Ait-Azzouzene D, Puri K, Vela JL, Nemazee D (2007) Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. J Immunol 178(10):6332–6341PubMedPubMedCentralCrossRef Verkoczy L, Duong B, Skog P, Ait-Azzouzene D, Puri K, Vela JL, Nemazee D (2007) Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. J Immunol 178(10):6332–6341PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Sater RA, Sandel PC, Monroe JG (1998) B cell receptor-induced apoptosis in primary transitional murine B cells: Signaling requirements and modulation by T cell help. Int Immunol 10(11):1673–1682PubMedCrossRef Sater RA, Sandel PC, Monroe JG (1998) B cell receptor-induced apoptosis in primary transitional murine B cells: Signaling requirements and modulation by T cell help. Int Immunol 10(11):1673–1682PubMedCrossRef
70.
Zurück zum Zitat King LB, Monroe JG (2000) Immunobiology of the immature B cell: Plasticity in the B-cell antigen receptor-induced response fine tunes negative selection. Immunol Rev 176:86–104PubMedCrossRef King LB, Monroe JG (2000) Immunobiology of the immature B cell: Plasticity in the B-cell antigen receptor-induced response fine tunes negative selection. Immunol Rev 176:86–104PubMedCrossRef
72.
Zurück zum Zitat Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC (1996) Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 381(6580):325–328. doi:10.1038/381325a0 PubMedCrossRef Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC (1996) Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 381(6580):325–328. doi:10.​1038/​381325a0 PubMedCrossRef
73.
Zurück zum Zitat Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A (2003) Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 198(7):1119–1126. doi:10.1084/jem.20030411 PubMedPubMedCentralCrossRef Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A (2003) Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 198(7):1119–1126. doi:10.​1084/​jem.​20030411 PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Strasser A, Puthalakath H, Bouillet P, Huang DC, O’Connor L, O’Reilly LA, Cullen L, Cory S, Adams JM (2000) The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Ann N Y Acad Sci 917:541–548PubMedCrossRef Strasser A, Puthalakath H, Bouillet P, Huang DC, O’Connor L, O’Reilly LA, Cullen L, Cory S, Adams JM (2000) The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Ann N Y Acad Sci 917:541–548PubMedCrossRef
75.
Zurück zum Zitat Strasser A, Puthalakath H, O’Reilly LA, Bouillet P (2008) What do we know about the mechanisms of elimination of autoreactive T and B cells and what challenges remain. Immunol Cell Biol 86(1):57–66. doi:10.1038/sj.icb.7100141 PubMedCrossRef Strasser A, Puthalakath H, O’Reilly LA, Bouillet P (2008) What do we know about the mechanisms of elimination of autoreactive T and B cells and what challenges remain. Immunol Cell Biol 86(1):57–66. doi:10.​1038/​sj.​icb.​7100141 PubMedCrossRef
76.
Zurück zum Zitat Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286(5445):1735–1738PubMedCrossRef Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286(5445):1735–1738PubMedCrossRef
77.
Zurück zum Zitat Cante-Barrett K, Gallo EM, Winslow MM, Crabtree GR (2006) Thymocyte negative selection is mediated by protein kinase C- and Ca2+-dependent transcriptional induction of bim [corrected]. J Immunol 176(4):2299–2306PubMedCrossRef Cante-Barrett K, Gallo EM, Winslow MM, Crabtree GR (2006) Thymocyte negative selection is mediated by protein kinase C- and Ca2+-dependent transcriptional induction of bim [corrected]. J Immunol 176(4):2299–2306PubMedCrossRef
79.
Zurück zum Zitat Marechal Y, Pesesse X, Jia Y, Pouillon V, Perez-Morga D, Daniel J, Izui S, Cullen PJ, Leo O, Luo HR, Erneux C, Schurmans S (2007) Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells. Proceedings of the National Academy of Sciences of the United States of America 104 (35):13978–13983. doi:10.1073/pnas.0704312104 Marechal Y, Pesesse X, Jia Y, Pouillon V, Perez-Morga D, Daniel J, Izui S, Cullen PJ, Leo O, Luo HR, Erneux C, Schurmans S (2007) Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells. Proceedings of the National Academy of Sciences of the United States of America 104 (35):13978–13983. doi:10.​1073/​pnas.​0704312104
83.
Zurück zum Zitat Mittelstadt PR, DeFranco AL (1993) Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J Immunol 150(11):4822–4832PubMed Mittelstadt PR, DeFranco AL (1993) Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J Immunol 150(11):4822–4832PubMed
87.
Zurück zum Zitat Limnander A, Depeille P, Freedman TS, Liou J, Leitges M, Kurosaki T, Roose JP, Weiss A (2011) STIM1, PKC-delta and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol 12(5):425–433. doi:10.1038/ni.2016 PubMedPubMedCentralCrossRef Limnander A, Depeille P, Freedman TS, Liou J, Leitges M, Kurosaki T, Roose JP, Weiss A (2011) STIM1, PKC-delta and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol 12(5):425–433. doi:10.​1038/​ni.​2016 PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Mecklenbrauker I, Saijo K, Zheng NY, Leitges M, Tarakhovsky A (2002) Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416(6883):860–865. doi:10.1038/416860a PubMedCrossRef Mecklenbrauker I, Saijo K, Zheng NY, Leitges M, Tarakhovsky A (2002) Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416(6883):860–865. doi:10.​1038/​416860a PubMedCrossRef
89.
Zurück zum Zitat Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, Nakayama KI (2002) Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416(6883):865–869. doi:10.1038/416865a PubMedCrossRef Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, Nakayama KI (2002) Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416(6883):865–869. doi:10.​1038/​416865a PubMedCrossRef
90.
Zurück zum Zitat Su TT, Guo B, Wei B, Braun J, Rawlings DJ (2004) Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev 197:161–178PubMedCrossRef Su TT, Guo B, Wei B, Braun J, Rawlings DJ (2004) Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev 197:161–178PubMedCrossRef
91.
Zurück zum Zitat Benschop RJ, Brandl E, Chan AC, Cambier JC (2001) Unique signaling properties of B cell antigen receptor in mature and immature B cells: implications for tolerance and activation. J Immunol 167(8):4172–4179PubMedCrossRef Benschop RJ, Brandl E, Chan AC, Cambier JC (2001) Unique signaling properties of B cell antigen receptor in mature and immature B cells: implications for tolerance and activation. J Immunol 167(8):4172–4179PubMedCrossRef
93.
Zurück zum Zitat Yellen AJ, Glenn W, Sukhatme VP, Cao XM, Monroe JG (1991) Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice. J Immunol 146(5):1446–1454PubMed Yellen AJ, Glenn W, Sukhatme VP, Cao XM, Monroe JG (1991) Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice. J Immunol 146(5):1446–1454PubMed
94.
Zurück zum Zitat King LB, Norvell A, Monroe JG (1999) Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells. J Immunol 162(5):2655–2662PubMed King LB, Norvell A, Monroe JG (1999) Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells. J Immunol 162(5):2655–2662PubMed
95.
Zurück zum Zitat Sproul TW, Malapati S, Kim J, Pierce SK (2000) Cutting edge: B cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J Immunol 165(11):6020–6023PubMedCrossRef Sproul TW, Malapati S, Kim J, Pierce SK (2000) Cutting edge: B cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J Immunol 165(11):6020–6023PubMedCrossRef
96.
Zurück zum Zitat Karnell FG, Brezski RJ, King LB, Silverman MA, Monroe JG (2005) Membrane cholesterol content accounts for developmental differences in surface B cell receptor compartmentalization and signaling. J Biol Chem 280(27):25621–25628. doi:10.1074/jbc.M503162200 PubMedCrossRef Karnell FG, Brezski RJ, King LB, Silverman MA, Monroe JG (2005) Membrane cholesterol content accounts for developmental differences in surface B cell receptor compartmentalization and signaling. J Biol Chem 280(27):25621–25628. doi:10.​1074/​jbc.​M503162200 PubMedCrossRef
100.
Zurück zum Zitat Pao LI, Lam KP, Henderson JM, Kutok JL, Alimzhanov M, Nitschke L, Thomas ML, Neel BG, Rajewsky K (2007) B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27(1):35–48. doi:10.1016/j.immuni.2007.04.016 PubMedCrossRef Pao LI, Lam KP, Henderson JM, Kutok JL, Alimzhanov M, Nitschke L, Thomas ML, Neel BG, Rajewsky K (2007) B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27(1):35–48. doi:10.​1016/​j.​immuni.​2007.​04.​016 PubMedCrossRef
102.
Zurück zum Zitat Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, Rao A (2002) Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109(6):719–731PubMedCrossRef Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, Rao A (2002) Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109(6):719–731PubMedCrossRef
103.
Zurück zum Zitat Toldi G, Bajnok A, Dobi D, Kaposi A, Kovacs L, Vasarhelyi B, Balog A (2013) The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis. Immunobiology 218(3):311–316. doi:10.1016/j.imbio.2012.05.013 PubMedCrossRef Toldi G, Bajnok A, Dobi D, Kaposi A, Kovacs L, Vasarhelyi B, Balog A (2013) The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis. Immunobiology 218(3):311–316. doi:10.​1016/​j.​imbio.​2012.​05.​013 PubMedCrossRef
105.
Zurück zum Zitat Toldi G, Vasarhelyi B, Kaposi A, Meszaros G, Panczel P, Hosszufalusi N, Tulassay T, Treszl A (2010) Lymphocyte activation in type 1 diabetes mellitus: The increased significance of Kv1.3 potassium channels. Immunol Lett 133(1):35–41. doi:10.1016/j.imlet.2010.06.009 PubMedCrossRef Toldi G, Vasarhelyi B, Kaposi A, Meszaros G, Panczel P, Hosszufalusi N, Tulassay T, Treszl A (2010) Lymphocyte activation in type 1 diabetes mellitus: The increased significance of Kv1.3 potassium channels. Immunol Lett 133(1):35–41. doi:10.​1016/​j.​imlet.​2010.​06.​009 PubMedCrossRef
106.
109.
Zurück zum Zitat O’Keefe TL, Williams GT, Batista FD, Neuberger MS (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189(8):1307–1313PubMedPubMedCentralCrossRef O’Keefe TL, Williams GT, Batista FD, Neuberger MS (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189(8):1307–1313PubMedPubMedCentralCrossRef
110.
Zurück zum Zitat Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13(2):277–285PubMedCrossRef Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13(2):277–285PubMedCrossRef
111.
Zurück zum Zitat Yu P, Constien R, Dear N, Katan M, Hanke P, Bunney TD, Kunder S, Quintanilla-Martinez L, Huffstadt U, Schroder A, Jones NP, Peters T, Fuchs H, de Angelis MH, Nehls M, Grosse J, Wabnitz P, Meyer TP, Yasuda K, Schiemann M, Schneider-Fresenius C, Jagla W, Russ A, Popp A, Josephs M, Marquardt A, Laufs J, Schmittwolf C, Wagner H, Pfeffer K, Mudde GC (2005) Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity 22(4):451–465. doi:10.1016/j.immuni.2005.01.018 PubMedCrossRef Yu P, Constien R, Dear N, Katan M, Hanke P, Bunney TD, Kunder S, Quintanilla-Martinez L, Huffstadt U, Schroder A, Jones NP, Peters T, Fuchs H, de Angelis MH, Nehls M, Grosse J, Wabnitz P, Meyer TP, Yasuda K, Schiemann M, Schneider-Fresenius C, Jagla W, Russ A, Popp A, Josephs M, Marquardt A, Laufs J, Schmittwolf C, Wagner H, Pfeffer K, Mudde GC (2005) Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity 22(4):451–465. doi:10.​1016/​j.​immuni.​2005.​01.​018 PubMedCrossRef
112.
Zurück zum Zitat Hasegawa M, Fujimoto M, Poe JC, Steeber DA, Lowell CA, Tedder TF (2001) A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice. J Immunol 167(5):2469–2478PubMedCrossRef Hasegawa M, Fujimoto M, Poe JC, Steeber DA, Lowell CA, Tedder TF (2001) A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice. J Immunol 167(5):2469–2478PubMedCrossRef
117.
Zurück zum Zitat Saadoun D, Terrier B, Bannock J, Vazquez T, Massad C, Kang I, Joly F, Rosenzwajg M, Sene D, Benech P, Musset L, Klatzmann D, Meffre E, Cacoub P (2013) Expansion of autoreactive unresponsive CD21−/low B cells in Sjogren’s syndrome-associated lymphoproliferation. Arthritis Rheum 65(4):1085–1096. doi:10.1002/art.37828 PubMedPubMedCentralCrossRef Saadoun D, Terrier B, Bannock J, Vazquez T, Massad C, Kang I, Joly F, Rosenzwajg M, Sene D, Benech P, Musset L, Klatzmann D, Meffre E, Cacoub P (2013) Expansion of autoreactive unresponsive CD21−/low B cells in Sjogren’s syndrome-associated lymphoproliferation. Arthritis Rheum 65(4):1085–1096. doi:10.​1002/​art.​37828 PubMedPubMedCentralCrossRef
118.
Zurück zum Zitat Oh-Hora M, Yamashita M, Hogan PG, Sharma S, Lamperti E, Chung W, Prakriya M, Feske S, Rao A (2008) Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol 9(4):432–443. doi:10.1038/ni1574 PubMedPubMedCentralCrossRef Oh-Hora M, Yamashita M, Hogan PG, Sharma S, Lamperti E, Chung W, Prakriya M, Feske S, Rao A (2008) Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol 9(4):432–443. doi:10.​1038/​ni1574 PubMedPubMedCentralCrossRef
119.
Zurück zum Zitat Cheng KT, Alevizos I, Liu X, Swaim WD, Yin H, Feske S, Oh-hora M, Ambudkar IS (2012) STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjogren’s syndrome. Proceedings of the National Academy of Sciences of the United States of America 109 (36):14544–14549. doi:10.1073/pnas.1207354109 Cheng KT, Alevizos I, Liu X, Swaim WD, Yin H, Feske S, Oh-hora M, Ambudkar IS (2012) STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjogren’s syndrome. Proceedings of the National Academy of Sciences of the United States of America 109 (36):14544–14549. doi:10.​1073/​pnas.​1207354109
120.
Zurück zum Zitat Picard C, McCarl CA, Papolos A, Khalil S, Luthy K, Hivroz C, LeDeist F, Rieux-Laucat F, Rechavi G, Rao A, Fischer A, Feske S (2009) STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 360(19):1971–1980. doi:10.1056/NEJMoa0900082 PubMedPubMedCentralCrossRef Picard C, McCarl CA, Papolos A, Khalil S, Luthy K, Hivroz C, LeDeist F, Rieux-Laucat F, Rechavi G, Rao A, Fischer A, Feske S (2009) STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 360(19):1971–1980. doi:10.​1056/​NEJMoa0900082 PubMedPubMedCentralCrossRef
121.
124.
Zurück zum Zitat Teos LY, Zhang Y, Cotrim AP, Swaim W, Won JH, Ambrus J, Shen L, Bebris L, Grisius M, Jang SI, Yule DI, Ambudkar IS, Alevizos I (2015) IP3R deficit underlies loss of salivary fluid secretion in Sjogren’s syndrome. Sci Rep 5:13953. doi:10.1038/srep13953 PubMedPubMedCentralCrossRef Teos LY, Zhang Y, Cotrim AP, Swaim W, Won JH, Ambrus J, Shen L, Bebris L, Grisius M, Jang SI, Yule DI, Ambudkar IS, Alevizos I (2015) IP3R deficit underlies loss of salivary fluid secretion in Sjogren’s syndrome. Sci Rep 5:13953. doi:10.​1038/​srep13953 PubMedPubMedCentralCrossRef
130.
Zurück zum Zitat Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, Lipsky PE, Radbruch A, Dorner T (2000) Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 165(10):5970–5979PubMedCrossRef Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, Lipsky PE, Radbruch A, Dorner T (2000) Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 165(10):5970–5979PubMedCrossRef
134.
Zurück zum Zitat Liossis SN, Hoffman RW, Tsokos GC (1998) Abnormal early TCR/CD3-mediated signaling events of a snRNP-autoreactive lupus T cell clone. Clin Immunol Immunopathol 88(3):305–310PubMedCrossRef Liossis SN, Hoffman RW, Tsokos GC (1998) Abnormal early TCR/CD3-mediated signaling events of a snRNP-autoreactive lupus T cell clone. Clin Immunol Immunopathol 88(3):305–310PubMedCrossRef
137.
Zurück zum Zitat Liossis SN, Kovacs B, Dennis G, Kammer GM, Tsokos GC (1996) B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest 98(11):2549–2557. doi:10.1172/JCI119073 PubMedPubMedCentralCrossRef Liossis SN, Kovacs B, Dennis G, Kammer GM, Tsokos GC (1996) B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest 98(11):2549–2557. doi:10.​1172/​JCI119073 PubMedPubMedCentralCrossRef
138.
Zurück zum Zitat Enyedy EJ, Mitchell JP, Nambiar MP, Tsokos GC (2001) Defective FcgammaRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus. Clin Immunol 101(2):130–135. doi:10.1006/clim.2001.5104 PubMedCrossRef Enyedy EJ, Mitchell JP, Nambiar MP, Tsokos GC (2001) Defective FcgammaRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus. Clin Immunol 101(2):130–135. doi:10.​1006/​clim.​2001.​5104 PubMedCrossRef
139.
Zurück zum Zitat Wu XN, Ye YX, Niu JW, Li Y, Li X, You X, Chen H, Zhao LD, Zeng XF, Zhang FC, Tang FL, He W, Cao XT, Zhang X, Lipsky PE (2014) Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med 6(246):246ra299. doi:10.1126/scitranslmed.3009131 CrossRef Wu XN, Ye YX, Niu JW, Li Y, Li X, You X, Chen H, Zhao LD, Zeng XF, Zhang FC, Tang FL, He W, Cao XT, Zhang X, Lipsky PE (2014) Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med 6(246):246ra299. doi:10.​1126/​scitranslmed.​3009131 CrossRef
140.
Zurück zum Zitat Fleischer SJ, Daridon C, Fleischer V, Lipsky PE, Dorner T (2016) Enhanced tyrosine Phosphatase activity underlies Dysregulated B cell receptor signaling and promotes survival of human lupus B cells. Arthritis & Rheumatology 68(5):1210–1221. doi:10.1002/art.39559 Fleischer SJ, Daridon C, Fleischer V, Lipsky PE, Dorner T (2016) Enhanced tyrosine Phosphatase activity underlies Dysregulated B cell receptor signaling and promotes survival of human lupus B cells. Arthritis & Rheumatology 68(5):1210–1221. doi:10.​1002/​art.​39559
144.
Zurück zum Zitat Liossis SN, Solomou EE, Dimopoulos MA, Panayiotidis P, Mavrikakis MM, Sfikakis PP (2001) B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 49(2):157–165. doi:10.2310/6650.2001.34042 CrossRef Liossis SN, Solomou EE, Dimopoulos MA, Panayiotidis P, Mavrikakis MM, Sfikakis PP (2001) B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 49(2):157–165. doi:10.​2310/​6650.​2001.​34042 CrossRef
145.
Zurück zum Zitat Flores-Borja F, Kabouridis PS, Jury EC, Isenberg DA, Mageed RA (2005) Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 52(12):3955–3965. doi:10.1002/art.21416 PubMedCrossRef Flores-Borja F, Kabouridis PS, Jury EC, Isenberg DA, Mageed RA (2005) Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 52(12):3955–3965. doi:10.​1002/​art.​21416 PubMedCrossRef
146.
Zurück zum Zitat Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3(5):549–560PubMedCrossRef Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3(5):549–560PubMedCrossRef
148.
Zurück zum Zitat Marquart HV, Svendsen A, Rasmussen JM, Nielsen CH, Junker P, Svehag SE, Leslie RG (1995) Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 101(1):60–65PubMedPubMedCentralCrossRef Marquart HV, Svendsen A, Rasmussen JM, Nielsen CH, Junker P, Svehag SE, Leslie RG (1995) Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 101(1):60–65PubMedPubMedCentralCrossRef
149.
Zurück zum Zitat Culton DA, Nicholas MW, Bunch DO, Zhen QL, Kepler TB, Dooley MA, Mohan C, Nachman PH, Clarke SH (2007) Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 27(1):53–68. doi:10.1007/s10875-006-9051-1 PubMedCrossRef Culton DA, Nicholas MW, Bunch DO, Zhen QL, Kepler TB, Dooley MA, Mohan C, Nachman PH, Clarke SH (2007) Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 27(1):53–68. doi:10.​1007/​s10875-006-9051-1 PubMedCrossRef
150.
Zurück zum Zitat Juang YT, Wang Y, Solomou EE, Li Y, Mawrin C, Tenbrock K, Kyttaris VC, Tsokos GC (2005) Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J Clin Invest 115(4):996–1005. doi:10.1172/JCI22854 PubMedPubMedCentralCrossRef Juang YT, Wang Y, Solomou EE, Li Y, Mawrin C, Tenbrock K, Kyttaris VC, Tsokos GC (2005) Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J Clin Invest 115(4):996–1005. doi:10.​1172/​JCI22854 PubMedPubMedCentralCrossRef
151.
152.
Zurück zum Zitat Otomo K, Koga T, Mizui M, Yoshida N, Kriegel C, Bickerton S, Fahmy TM, Tsokos GC (2015) Cutting edge: nanogel-based delivery of an inhibitor of CaMK4 to CD4+ T cells suppresses experimental autoimmune encephalomyelitis and lupus-like disease in mice. J Immunol 195(12):5533–5537. doi:10.4049/jimmunol.1501603 PubMedPubMedCentralCrossRef Otomo K, Koga T, Mizui M, Yoshida N, Kriegel C, Bickerton S, Fahmy TM, Tsokos GC (2015) Cutting edge: nanogel-based delivery of an inhibitor of CaMK4 to CD4+ T cells suppresses experimental autoimmune encephalomyelitis and lupus-like disease in mice. J Immunol 195(12):5533–5537. doi:10.​4049/​jimmunol.​1501603 PubMedPubMedCentralCrossRef
157.
Zurück zum Zitat Byun M, Abhyankar A, Lelarge V, Plancoulaine S, Palanduz A, Telhan L, Boisson B, Picard C, Dewell S, Zhao C, Jouanguy E, Feske S, Abel L, Casanova JL (2010) Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med 207(11):2307–2312. doi:10.1084/jem.20101597 PubMedPubMedCentralCrossRef Byun M, Abhyankar A, Lelarge V, Plancoulaine S, Palanduz A, Telhan L, Boisson B, Picard C, Dewell S, Zhao C, Jouanguy E, Feske S, Abel L, Casanova JL (2010) Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med 207(11):2307–2312. doi:10.​1084/​jem.​20101597 PubMedPubMedCentralCrossRef
158.
Zurück zum Zitat Fuchs S, Rensing-Ehl A, Speckmann C, Bengsch B, Schmitt-Graeff A, Bondzio I, Maul-Pavicic A, Bass T, Vraetz T, Strahm B, Ankermann T, Benson M, Caliebe A, Folster-Holst R, Kaiser P, Thimme R, Schamel WW, Schwarz K, Feske S, Ehl S (2012) Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J Immunol 188(3):1523–1533. doi:10.4049/jimmunol.1102507 PubMedCrossRef Fuchs S, Rensing-Ehl A, Speckmann C, Bengsch B, Schmitt-Graeff A, Bondzio I, Maul-Pavicic A, Bass T, Vraetz T, Strahm B, Ankermann T, Benson M, Caliebe A, Folster-Holst R, Kaiser P, Thimme R, Schamel WW, Schwarz K, Feske S, Ehl S (2012) Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J Immunol 188(3):1523–1533. doi:10.​4049/​jimmunol.​1102507 PubMedCrossRef
159.
Zurück zum Zitat McCarl CA, Picard C, Khalil S, Kawasaki T, Rother J, Papolos A, Kutok J, Hivroz C, Ledeist F, Plogmann K, Ehl S, Notheis G, Albert MH, Belohradsky BH, Kirschner J, Rao A, Fischer A, Feske S (2009) ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol 124(6):1311–1318 e1317. doi:10.1016/j.jaci.2009.10.007 PubMedPubMedCentralCrossRef McCarl CA, Picard C, Khalil S, Kawasaki T, Rother J, Papolos A, Kutok J, Hivroz C, Ledeist F, Plogmann K, Ehl S, Notheis G, Albert MH, Belohradsky BH, Kirschner J, Rao A, Fischer A, Feske S (2009) ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol 124(6):1311–1318 e1317. doi:10.​1016/​j.​jaci.​2009.​10.​007 PubMedPubMedCentralCrossRef
161.
Zurück zum Zitat Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441(7090):179–185. doi:10.1038/nature04702 PubMedCrossRef Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441(7090):179–185. doi:10.​1038/​nature04702 PubMedCrossRef
163.
Zurück zum Zitat Schaballie H, Rodriguez R, Martin E, Moens L, Frans G, Lenoir C, Dutre J, Canioni D, Bossuyt X, Fischer A, Latour S, Meyts I, Picard C (2015) A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency. J Allergy Clin Immunol 136(3):816–819 e814. doi:10.1016/j.jaci.2015.03.009 PubMedCrossRef Schaballie H, Rodriguez R, Martin E, Moens L, Frans G, Lenoir C, Dutre J, Canioni D, Bossuyt X, Fischer A, Latour S, Meyts I, Picard C (2015) A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency. J Allergy Clin Immunol 136(3):816–819 e814. doi:10.​1016/​j.​jaci.​2015.​03.​009 PubMedCrossRef
164.
Zurück zum Zitat Gwack Y, Srikanth S, Oh-Hora M, Hogan PG, Lamperti ED, Yamashita M, Gelinas C, Neems DS, Sasaki Y, Feske S, Prakriya M, Rajewsky K, Rao A (2008) Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol 28(17):5209–5222. doi:10.1128/MCB.00360-08 PubMedPubMedCentralCrossRef Gwack Y, Srikanth S, Oh-Hora M, Hogan PG, Lamperti ED, Yamashita M, Gelinas C, Neems DS, Sasaki Y, Feske S, Prakriya M, Rajewsky K, Rao A (2008) Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol 28(17):5209–5222. doi:10.​1128/​MCB.​00360-08 PubMedPubMedCentralCrossRef
165.
Zurück zum Zitat McCarl CA, Khalil S, Ma J, Oh-hora M, Yamashita M, Roether J, Kawasaki T, Jairaman A, Sasaki Y, Prakriya M, Feske S (2010) Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J Immunol 185(10):5845–5858. doi:10.4049/jimmunol.1001796 PubMedPubMedCentralCrossRef McCarl CA, Khalil S, Ma J, Oh-hora M, Yamashita M, Roether J, Kawasaki T, Jairaman A, Sasaki Y, Prakriya M, Feske S (2010) Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J Immunol 185(10):5845–5858. doi:10.​4049/​jimmunol.​1001796 PubMedPubMedCentralCrossRef
167.
168.
Zurück zum Zitat Feske S, Muller JM, Graf D, Kroczek RA, Drager R, Niemeyer C, Baeuerle PA, Peter HH, Schlesier M (1996) Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol 26(9):2119–2126. doi:10.1002/eji.1830260924 PubMedCrossRef Feske S, Muller JM, Graf D, Kroczek RA, Drager R, Niemeyer C, Baeuerle PA, Peter HH, Schlesier M (1996) Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol 26(9):2119–2126. doi:10.​1002/​eji.​1830260924 PubMedCrossRef
169.
Metadaten
Titel
Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.
verfasst von
Patrice Hemon
Yves Renaudineau
Marjolaine Debant
Nelig Le Goux
Sreya Mukherjee
Wesley Brooks
Olivier Mignen
Publikationsdatum
13.05.2017
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 2/2017
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-017-8607-6

Weitere Artikel der Ausgabe 2/2017

Clinical Reviews in Allergy & Immunology 2/2017 Zur Ausgabe

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.